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Abstract
Fatty acid composition of serum lipids and adipose tissue triacylglycerols (AT-TAG) partly reflect
dietary fatty acid intake. The fatty acid composition is, besides the diet, also influenced by
desaturating enzymes that can be estimated using product-to-precursor fatty acid ratios. The
interrelationships between desaturase indices derived from different serum lipid fractions and
adipose tissue are unclear, as well as their associations with obesity and insulin resistance. We
aimed to investigate cross-sectional correlations between desaturase indices as measured in serum
lipid fractions (phospholipids; PL and free fatty acids; FFA) and in adipose tissue (AT-TAG). In a
population-based sample of 301 healthy 60-year-old men various desaturase indices were assessed:
stearoyl-CoA-desaturase (16:1n-7/16:0; SCD-16 and 18:1n-9/18:0; SCD-18, respectively), delta-6-
desaturase (20:3n-6/18:2n-6; D6D) and delta-5-desaturase (20:4n-6/20:3n-6; D5D). Correlations
with BMI and insulin resistance (HOMA-IR) were also examined. SCD-16 and D5D were
significantly correlated between fractions and tissues (all r > 0.30), whereas SCD-18 and D6D were
not. Desaturase indices in serum FFA and AT-TAG were significantly correlated; SCD-16 (r =
0.63), SCD-18 (r = 0.37), and D5D (r = 0.43). In phospholipids, SCD-16 was positively correlated
to BMI (r = 0.15), while D5D negatively to both BMI (r = -0.30) and HOMA-IR (r = -0.31), all p <
0.01. D6D in both phospholipids and AT-TAG was positively correlated to HOMA-IR and BMI (all
p < 0.01). In conclusion, SCD-1 and D5D activity indices showed overall strong correlations
between lipid pools. SCD-1 activity index in adipose tissue is best reflected by 16:1/16:0-ratio in
serum FFA, but associations with obesity and insulin resistance differ between these pools. D5D in
PL was inversely related to obesity and insulin resistance, whereas D6D index showed positive
associations.
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Findings
The fatty acid composition of serum lipids and adipose
tissue triacylglycerols reflect the dietary fat intake over the
previous weeks and years, respectively [1-4]. The fatty
acids composition is also influenced by desaturating
enzymes and lifestyle factors such as smoking and physi-
cal activity [1,5]. Free fatty acids (FFA) are mainly released
from adipose tissue by lipolysis and provide energy to a
number of organs and serve as substrate for re-esterifica-
tion of triacylglycerols [6]. Serum fatty acids and desatu-
rase indices have been related to obesity [7], insulin
resistance [8], type-2-diabetes [9] and the metabolic syn-
drome [10]. Desaturase indices, estimated as product-to-
precursor fatty acid ratios, are employed in epidemiologi-
cal studies. However, little data exist on how these indices
relate to each other between different lipid pools and tis-
sues. Accumulating evidence suggest that Stearoyl-CoA-
Desaturase (SCD-1) enzyme activity may be regulated dif-
ferently in adipose tissue and liver, and its link with insu-
lin resistance and obesity may differ between these pools.
The primary aim of the present study was to investigate
associations between desaturase indices in serum phos-
pholipids, FFA and adipose tissue triacylglycerols (AT-
TAG). Secondary, associations between desaturase indices
and risk markers were studied.
The study participants, 301 healthy men, were selected
from a cohort of 60 year old Swedish men and women.
The recruitment procedures and investigations have been
previously described [11,12]. For the analysis of adipose
tissue fatty acids a needle biopsy of subcutaneous adipose
tissue was taken from the upper left buttock [13]. Blood
samples were collected from the antecubital vein. Serum
and adipose tissue samples were stored up to one year (-
70°C) before analysis. The fatty acid composition of
serum phospholipids, FFA and AT-TAG was measured as
previously described [14]. Briefly, the samples were
extracted in chloroform, separated by thin-layer -chroma-
tography (this step was not carried out for AT-TAG), trans-
methylated and then separated by gas liquid chromatog-
raphy with a system from Hewlett-Packard (Avondale,
PA)) on a capillary column (Quadrex, New Heaven, CT,
USA). Methyl ester standards (GLC- 68A, Nu Check Prep,
Elysian, MN, USA) were used to identify the different fatty
acids. Desaturase indices were estimated according to the
following: SCD-16: 16:1(n-7)/16:0, SCD-18: 18:1(n-9)/
18:0, D6D: 20:3(n-6)/18:2 (n-6) and D5D: 20:4(n-6)/
20:3 (n-6). Insulin resistance was estimated by HOMA-IR
(fasting insulin (mU/l) × fasting glucose (mmol/l)/22.5)
[15]. The statistical analysis was carried out with the soft-
ware package STATA (version 8.2; STATA Corporation, TX,
USA). Correlations were investigated with Spearman's
rank correlation test and the test was significant at p <
0.05. No imputing for missing data was done.
The baseline characteristics of the study population are
presented in Table 1. SCD-16 index was correlated
between fractions and tissues and the strongest correla-
tion was not surprisingly established between FFA and AT-
TAG (Table 2 and the Figure 1). SCD-18 in free fatty acids
was significantly correlated to both SCD-18 in phosphol-
ipids and AT-TAG. D5D was also correlated between tis-
sues and fraction with the strongest correlation between
FFA and AT-TAG. D6D in phospholipids and AT-TAG
were correlated. SCD-16 index in phospholipids and AT-
TAG was positively correlated to BMI, whilst SCD-16 in
FFA was surprisingly negatively correlated to the HOMA-
IR (Table 3). SCD-18 in AT-TAG was positively and in
phospholipids negatively correlated to BMI and HOMA-
IR. SCD-18 in FFA was also positively correlated to BMI.
Table 1: Baseline characteristics of the study subjects.
Baseline characteristics N
Age (years) 63 (0.7) 301
BMI (kg/m2) 25.9 (3.1) 301
Total cholesterol (mmol/l) 5.9 (1.0) 301
LDL-cholesterol (mmol/l) 3.7 (1.0) 301
HDL-cholesterola (mmol/l) 1.6 (1.4–1.8) 301
Triacylglycerola (mmol/l) 1.1 (0.8–1.4) 301
Fasting insulina (mU/l) 5.8 (4.2–8.0) 301
Fasting glucosea (mmol/l) 4.9 (4.6–5.2) 301
HOMA-IRa 1.3 (0.9–1.8) 300
Tobacco users (%) 23 301
Adipose tissue desaturase indices
SCD-16 0.36 (0.1) 297
SCD-18 14.8 (3.6) 297
D6Da 17(14–20) × 10-3 286
D5D 2.5 (0.6) 286
Free fatty acid desaturase indices
SCD-16 0.15 (0.04) 300
SCD-18 3.95 (0.73) 300
D6Da 33 (23–55) × 10-3 51
D5Da 3.1 (2.2–4.1) 51
Phospholipid desaturase indices
SCD-16a 0.02 (0.017–0.023) 299
SCD-18 0.94 (0.12) 299
D6Da 0.15(0.13–0.18) 299
D5D 3.0 (0.71) 299
Mean and standard deviation are presented for normally distributed 
variables and median and interquartile range (25th–75th percentiles) 
for skewed variables.
a Skewed variable
HOMA Homeostasis model insulin resistance
SCD Stearoyl-CoA-desaturase (SCD-16 = 16:1(n-7)/16:0, SCD-18 = 
18:1(n-9)/18:0)
D5D delta-5-desaturase (20:4(n-6)/20:3 (n-6))
D6D delta-6-desaturase (20:3(n-6)/18:2 (n-6))Lipids in Health and Disease 2009, 8:37 http://www.lipidworld.com/content/8/1/37
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D5D in phospholipids were negatively associated with
BMI and HOMA-IR, whereas D5D of AT-TAG was corre-
lated to neither BMI or to HOMA-IR. D6D in both phos-
pholipids and AT-TAG was positively correlated to
HOMA-IR and BMI. The correlation between D5D in
phospholipids and D6D in AT-TAG and HOMA-IR
remained after adjustment for BMI.
Correlations between desaturase ratios in FFA, PL and AT-
TAG
This study confirms and extends information regarding
desaturase indices in different lipid pools as well as in
relation to obesity and insulin action. Estimated SCD-16
and D5D activities were both highly correlated between
fraction and tissues, whereas D6D and SCD-18 was not.
Associations between serum free fatty acids and AT-TAG
for estimated SCD-16, SCD-18 and D5D, were strong and
reflects the release of free fatty acids from adipose tissue
into the circulation during lipolysis [16]. The correlation
between serum free fatty acids and AT-TAG for estimated
SCD-16 was the strongest, r = 0.63, p = 0.000. It is possible
that the SCD-16 index in FFA to a large part reflect the
SCD enzyme activity in adipose tissue, while estimated
SCD in other serum fractions, cholesteryl esters and tria-
cylglycerols, may mainly reflect liver SCD enzyme activity.
This is useful information for future epidemiological stud-
ies that aim to examine adipose tissue SCD enzyme activ-
ity, and differentiate this index from the serum pools
mainly reflecting liver SCD activities, i.e. cholesteryl
esters, and triacylglycerols [17].
The use of SCD indices derived from phospholipids is
however more unclear since there is significant of
exchange of fatty acids within systemic circulation
between lipid pools [17]. Further it is uncertain which tis-
sue SCD index from phospholipids would reflect. Thus,
interpretation of desaturation indices using phospholip-
ids requires caution. To estimate SCD activity of the liver,
triacylglycerol is in theory the optimal lipid fraction. Data
on this fraction would have been useful to help under-
stand the role of different lipid fractions and its link to
liver versus adipose tissue, but were unfortunately not
available in the present study. Analyses by Summers et al.
[18] of 16:0 and 18:2 n-6 in platelet phospholipids,
plasma cholesteryl esters, plasma triacylglycerols and
plasma FFA however showed a strong concordance
Table 2: Spearman rank correlations between estimated fatty acid desaturases in serum phospholipids, serum free fatty acids and 
adipose tissue triacylglycerols.
Serum free fatty acids Adipose tissue triacylglycerols
SCD-16 SCD-16
r P nr P n
SCD-16 PL 0.54 0.000 299 0.39 0.000 295
FFA - - - 0.63 0.000 296
SCD-18 SCD-18
r P nr P n
SCD-18 PL 0.17 0.004 299 -0.05 0.44 295
FFA - - - 0.37 0.000 296
D6D D6D
r P nr P n
D6D PL -0.13 0.44 39 0.53 0.000 295
FFA - - - -0.06 0.69 48
D5D D5D
r P nr P n
D5D PL 0.31 0.03 50 0.36 0.000 284
FFA - - - 0.43 0.002 48
SCD Stearoyl-CoA-desaturase (SCD-16 = 16:1(n-7)/16:0, SCD-18 = 18:1(n-9)/18:0)
D5D delta-5-desaturase (20:4(n-6)/20:3 (n-6))
D6D delta-6-desaturase 20:3(n-6)/18:2 (n-6)
PL Serum phospholipids
FFA serum free fatty acids
TAG TriacylglycerolsLipids in Health and Disease 2009, 8:37 http://www.lipidworld.com/content/8/1/37
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between plasma FFA and plasma TG. Such data suggest
that several lipid fractions including FFA may reflect liver
SCD1 to some extent. Although FFA at first glance should
mainly reflect adipose tissue, it is possible that FFA may
resemble a combination of adipose tissue SCD1 and liver
SCD1, due to exchange of fatty acids between liver and
adipose tissue.
It should further be noted that we have not controlled for
the potential influence of dietary fatty acids on desatura-
tion indices. Thus, although fatty acid ratios for estimating
desaturation activities are meant to reflect enzyme activity
other environmental factors including fatty acid intake
may influence these ratios [5]. This study investigates the
interrelationships between different desaturation indices,
rather than exploring what different factors that may
determine the level of these desaturation indices.
In the present study, the SCD-18 index in phospholipids
and AT-TAG were not correlated. This might be due to
endogenous processes such as the elongation of palmitic
acid (16:0) to stearic acid (18:0) or the rapid conversion
of 18:0 to oleic acid (18:1) [19], or that 18:1 is preferen-
tially retained in adipose tissue [20]. Thus, a high SCD-18
index in serum phospholipids is more influenced by a diet
high in 18:1 [21]. However, a high SCD-18 index in AT-
TAG might be related to lipogenesis and therefore related
to risk factors in the present study.
Desaturase indices and risk factors
SCD-18 and SCD-16
The SCD index can be estimated as 16:1/16:0 or 18:1/18:0
and it is the former that has most consistently been related
to metabolic complications [22]. When SCD-18 in phos-
pholipids was used in the analyses it was negatively corre-
lated to BMI and HOMA-index, while the relations
between SCD-18 in AT-TAG and the same variables were
positive, which are difficult results to interpret, but in
analogy with the findings in a sub-group of the present
study population by Sjögren et al [23]. In that study, the
associations between desaturase mRNA expression and
desaturase indices in adipose tissue and insulin resistance
were investigated. Insulin-resistant subjects had a higher
adipose tissue SCD-18, but not SCD-16, compared to
insulin-sensitive subjects. This was also found in the
present study. It was further suggested that desaturation
indices in adipose tissue reflected the expression of SCD,
but not of D5D or D6D in adipose tissue [23]. Neither
D5D nor D6D indices in FFA correlated to risk factors in
the present study, which is compatible with the results of
Sjögren et al [23].
SCD-16, D6D and D5D
Previously, a high SCD-16 and D6D index was associated
with obesity [7] and predicted the metabolic syndrome,
associations that was confounded by obesity [10]. How-
ever, the D5D serum index was inversely related to obesity
[7] and the development of the metabolic syndrome, but
this association was independent of obesity [10]. A high
D5D index in serum phospholipids and muscle has been
related to enhanced insulin action in both Pima Indians
[24] and Caucasian men [25]. Pan et al. [24] reported
D5D index to be independently associated with obesity.
The present results extend these previous observations
and confirm that the SCD-16 index is primarily related to
obesity, but not to insulin resistance, while the D5D index
is independently related both to glucometabolic risk and
obesity. D6D in phospholipids and AT-TAG were corre-
lated to BMI and insulin resistance, which align with the
notion that a high D6D index is associated with risk for
the metabolic syndrome [10]. The negative association
between SCD-16 in FFA and HOMA-IR is difficult to inter-
pret and may be due to chance and requires further study.
Possible mechanisms
Desaturases catalyze the synthesis of unsaturated fatty
acids that are incorporated into cell membranes which
thereby affect permeability and functional properties of
cells. This may affect insulin signalling and receptor bind-
ing affinities. Besides, long chain polyunsaturated fatty
acids synthesized by D5D and D6D may serve as ligands
Table 3: Spearman rank correlations between estimated 
desaturase activities in serum phospholipids and adipose tissue 
triacylglycerols and clinical variables.
BMI HOMA- IR
r P nr P n
SCD-16 PL 0.15 0.009 299 0.08 0.17 298
FFA 0.08 0.18 300 -0.16 0.006 299
AT-TAG 0.17 0.004 297 -0.02 0.78 296
SCD-18 PL -0.31 0.000 299 -0.41 0.000 298
FFA 0.15 0.009 300 0.05 0.40 299
AT-TAG 0.35 0.000 297 0.24 0.000 296
D6D PL 0.36 0.000 299 0.32 0.01 298
FFA -0.13 0.37 51 -.0002 1.0 51
AT-TAG 0.36 0.000 297 0.34 0.000 296
D5D PL -0.30 0.000 299 -0.31 0.000 298
FFA 0.03 0.8 51 -0.16 0.27 51
AT-TAG 0.03 0.6 286 -0.04 0.46 285
SCD Stearoyl-CoA-desaturase (SCD-16 = 16:1(n-7)/16:0, SCD-18 = 
18:1(n-9)/18:0)
D5D delta-5-desaturase (20:4(n-6)/20:3 (n-6))
D6D delta-6-desaturase (20:3(n-6)/18:2 (n-6)
PL Serum phospholipids
AT TAG adipose tissue triacylglycerols
BMI body mass index
HOMA IR Homeostasis model of insulin resistanceLipids in Health and Disease 2009, 8:37 http://www.lipidworld.com/content/8/1/37
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for transcription factors, such as sterol regulatory element
binding protein1 and peroxisome proliferators activated
receptors which interact with genes involved in lipogene-
sis and fatty acid oxidation. There is also a potential link
between D5D and D6D activities and insulin resistance
via inflammatory mediators, eicosanoids [20]. The SCD1
enzyme desaturates 16:0 and 18:0 as a direct result from
de novo lipogenesis (DNL) or derived from the diet [17].
In the present population consuming a Western diet with
a total fat intake of about 35% [12], the contribution of
fatty acids from DNL is thought to be of lesser importance
[26]. It is known that SCD1 activity is up-regulated in the
liver in parallel to DNL on a high carbohydrate diet
(75E%) but not at a high fat diet (40E%) [27]. Relation-
ships between desaturases and insulin resistance may be
directed in either direction; either disturbances in desatu-
rases lead to metabolic changes or metabolic changes
themselves lead to adaptive changes in desaturating
enzymes in order to cope with an aberrant situation.
In conclusion, the SCD-1 and D5D indices showed strong
correlations between lipid pools and tissues. We hypoth-
esize that the SCD-16 index in FFA to a large part reflect
the SCD enzyme activity in adipose tissue, while the SCD
index in triacylglycerols and cholesteryl esters mainly
reflect liver SCD enzyme activity. This is useful informa-
tion to have when studying desaturase indices in epidemi-
ological studies. SCD-16 in adipose tissue was related to
BMI but not insulin resistance. D5D in phospholipids was
inversely related to both these factors and D6D index
showed positive associations.
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